Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:


A glimpse into the genetic basis of schizophrenia


Novel genetic associations might enlighten underlying molecular mechanisms of schizophrenia and provide biomarkers for future diagnosis

For schizophrenia, biomarkers or supportive diagnostic tests are scarce and for many patients the efficacy of pharmacological treatment is limited. The PGC-SZ (Psychiatric Genomics Consortium - Schizophrenia), including scientists from the Max Planck Institute of Psychiatry in Munich, has now identified more than 100 genetic loci related to schizophrenia.

Artistic view of how life feels after the diagnosis of schizophrenia.

© Glen Brady, Queensland Centre for Mental Health Research

The results point to molecules that are currently the most promising targets for therapeutics also aligning well with recent theories about factors causing schizophrenia. The novel findings provide a relevant foundation for mechanistic and treatment development studies.

Schizophrenia is known to be a heritable disorder, highlighting inherited genetic variants to be a key causative for this disease. Due to the scarcity of biomarkers or supportive diagnostic tests, diagnosis is almost exclusively clinician-based. Furthermore, although pharmacological treatments are available for schizophrenia, their efficacy is limited for many patients.

The PGC-SZ, including Bertram Müller-Myhsok, Research Group Leader at the Max Planck Institute of Psychiatry in Munich, has now performed a genome-wide association study and identified more than 100 genomic loci that are significantly related to schizophrenia.

“Our findings include molecules that are currently the most promising targets for therapeutics and point to molecular systems aligning with the predominant theories on factors causing schizophrenia,” states Bertram Müller-Myhsok. “This might suggest that the many novel findings we report also provide a relevant foundation for treatment development studies.”

Particularly variations in genes related to altered glutamatergic synaptic and calcium channel function might serve as a panel of biomarkers for future diagnosis of schizophrenia or might allow better understanding of the molecular mechanisms underlying the disease.

Such associations with genes playing a role in the central nervous system are most relevant for the development of treatment strategies. The results of the study verified genetic associations with the gene coding for the type 2 dopaminergic receptor (DRD2).

“All available antipsychotic drugs are thought to exert their main therapeutic effects through blockade of DRD2,” explains Bertram Müller-Myhsok. “Since the discovery of this mechanism over 60 years ago, no new antipsychotic drug of proven efficacy has been developed based on other target molecules.” Thus, therapeutic stasis is in large part a consequence of the fact that the disease-causing mechanisms are still unknown. Identifying the causes of schizophrenia is therefore a critical step towards improving treatment and outcome for patients suffering from this disorder.


Dr. Bertram Müller-Myhsok

Max Planck Institute of Psychiatry, München

Phone: +49 89 30622-246


Anna Niedl

Press and Public Relations

Max Planck Institute of Psychiatry, München

Phone: +49 89 30622-263
Fax: +49 89 30622-370


Original publication

Schizophrenia Working Group of the Psychiatric Genomics Consortium.
Biological insights from 108 schizophrenia-associated genetic loci.
Nature, 22. Juli 2014 (doi:10.1038/nature13595)AN/HR

Dr. Bertram Müller-Myhsok | Max-Planck-Institute

Further reports about: Psychiatry biomarkers disorder findings mechanisms schizophrenia therapeutic

More articles from Life Sciences:

nachricht Novel mechanisms of action discovered for the skin cancer medication Imiquimod
21.10.2016 | Technische Universität München

nachricht Second research flight into zero gravity
21.10.2016 | Universität Zürich

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: New 3-D wiring technique brings scalable quantum computers closer to reality

Researchers from the Institute for Quantum Computing (IQC) at the University of Waterloo led the development of a new extensible wiring technique capable of controlling superconducting quantum bits, representing a significant step towards to the realization of a scalable quantum computer.

"The quantum socket is a wiring method that uses three-dimensional wires based on spring-loaded pins to address individual qubits," said Jeremy Béjanin, a PhD...

Im Focus: Scientists develop a semiconductor nanocomposite material that moves in response to light

In a paper in Scientific Reports, a research team at Worcester Polytechnic Institute describes a novel light-activated phenomenon that could become the basis for applications as diverse as microscopic robotic grippers and more efficient solar cells.

A research team at Worcester Polytechnic Institute (WPI) has developed a revolutionary, light-activated semiconductor nanocomposite material that can be used...

Im Focus: Diamonds aren't forever: Sandia, Harvard team create first quantum computer bridge

By forcefully embedding two silicon atoms in a diamond matrix, Sandia researchers have demonstrated for the first time on a single chip all the components needed to create a quantum bridge to link quantum computers together.

"People have already built small quantum computers," says Sandia researcher Ryan Camacho. "Maybe the first useful one won't be a single giant quantum computer...

Im Focus: New Products - Highlights of COMPAMED 2016

COMPAMED has become the leading international marketplace for suppliers of medical manufacturing. The trade fair, which takes place every November and is co-located to MEDICA in Dusseldorf, has been steadily growing over the past years and shows that medical technology remains a rapidly growing market.

In 2016, the joint pavilion by the IVAM Microtechnology Network, the Product Market “High-tech for Medical Devices”, will be located in Hall 8a again and will...

Im Focus: Ultra-thin ferroelectric material for next-generation electronics

'Ferroelectric' materials can switch between different states of electrical polarization in response to an external electric field. This flexibility means they show promise for many applications, for example in electronic devices and computer memory. Current ferroelectric materials are highly valued for their thermal and chemical stability and rapid electro-mechanical responses, but creating a material that is scalable down to the tiny sizes needed for technologies like silicon-based semiconductors (Si-based CMOS) has proven challenging.

Now, Hiroshi Funakubo and co-workers at the Tokyo Institute of Technology, in collaboration with researchers across Japan, have conducted experiments to...

All Focus news of the innovation-report >>>



Event News

#IC2S2: When Social Science meets Computer Science - GESIS will host the IC2S2 conference 2017

14.10.2016 | Event News

Agricultural Trade Developments and Potentials in Central Asia and the South Caucasus

14.10.2016 | Event News

World Health Summit – Day Three: A Call to Action

12.10.2016 | Event News

Latest News

Resolving the mystery of preeclampsia

21.10.2016 | Health and Medicine

Stanford researchers create new special-purpose computer that may someday save us billions

21.10.2016 | Information Technology

From ancient fossils to future cars

21.10.2016 | Materials Sciences

More VideoLinks >>>